Pretax income is the income that a company earns before paying income taxes. AtriCure's pretax income for the
three
months ended in Dec. 2023 was $-9.4 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-29.8 Mil.
AtriCure's pretax margin was -8.84%.
During the past 13 years, AtriCure's highest Pretax Margin was 18.37%. The lowest was -23.26%. And the median was -15.11%.
AtriCure Pre-Tax Income Historical Data
The historical data trend for AtriCure's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of AtriCure's Pre-Tax Income
For the Medical Instruments & Supplies subindustry, AtriCure's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AtriCure's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AtriCure's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where AtriCure's Pre-Tax Income falls into.
AtriCure Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
AtriCure's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-29.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AtriCure (NAS:ATRC) Pre-Tax Income Explanation
AtriCure's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, AtriCure's highest Pretax Margin was 18.37%. The lowest was -23.26%. And the median was -15.11%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AtriCure Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of AtriCure's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ATRC has been successfully added to your 